Abstract
Background: Uncertainty about the benefit-risk ratio of regional lymph node irradiation led to varying clinical protocols. We investigated long-term late side effects after internal mammary and medial supraclavicular (IM-MS) lymph node irradiation to improve shared decision making. Methods: The multicenter European Organization for Research and Treatment of Cancer trial (ClinicalTrials.gov,
... read more